Aardvark Therapeutics, Inc. Common Stock (AARD)
Healthcare
Biotechnology
7.10 $
+7.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Aardvark Therapeutics, Inc. Common Stock (AARD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -54 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -11 | -5.8 | -18 | -54 | |
| 0.1 | 0.1 | 0.0 | -1.3 | |
| 0.4 | 0.3 | 0.4 | 3.9 | |
| -1.3 | -0.1 | 1.6 | 0.4 | |
| 0.0 | 0.0 | 0.1 | 0.1 | |
| -1.0 | – | -12 | -50 | |
| – | – | – | 0.2 | |
| 0.2 | 0.0 | 82 | 89 | |
| -11 | -5.8 | 52 | -15 | |
| -11 | -5.8 | -18 | -54 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.